The story of Sildenafil presents a challenging picture for investors. While the initial introduction generated significant profits, the expiration of its exclusive rights opened the floodgates to off-brand competitors, dramatically eroding market share. This poses a particular challenge for pharmaceutical companies relying on related blockbuster pr

The story of Viagra, and its creator copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in sales , its intellectual property lapse created a deluge of generic competition , significantly impacting its market share . While certain businesses may seek to capitalize on related treatments , the pre